Health Science Faculty, Department of Physiotherapy and Rehabilitation, Gazi University, Ankara, Turkey.
Department of Physical Medicine and Rehabilitation, Ministry of Health, Istanbul Training and Research Hospital, Istanbul, Turkey.
Pain Med. 2018 Mar 1;19(3):615-628. doi: 10.1093/pm/pnx263.
The aim of this study was to evaluate the effects of acupuncture treatment on serum levels of serotonin and substance P (SP) as well as on clinical parameters in patients with fibromyalgia (FM).
This is a randomized controlled clinical trial. Seventy-five women with FM were randomized into one of three kinds of acupuncture treatment: real acupuncture group (AcG), sham acupuncture group (ShG), and simulated acupuncture group (SiG). Treatments were applied semiweekly for four weeks. The serum levels of serotonin and SP were evaluated before and after the eight sessions. Patients were clinically assessed by visual analog scale (VAS), the number of tender points (NTP), Fibromyalgia Impact Questionnaire (FIQ), Beck Depression Inventory (BDI), and Nottingham Health Profile (NHP) at baseline, after the last treatment, and one and three months after completion of all treatments.
Serum serotonin values increased significantly after treatment in AcG and ShG (P < 0.001 and P < 0.01, respectively). The increase in the AcG was also different from both of the other groups (P < 0.01). While SP levels decreased in the AcG, they increased in the SiG (P = 0.001). In the AcG, significant improvements were found in almost all clinical outcomes after treatment. These usually continued for three months. In the ShG, there were also significant changes on the NTP, VAS, FIQ, and BDI scores after treatment. Improvements on the NTP and FIQ scores lasted for three months. In the SiG, significant improvements were found only in the NTP, VAS, and BDI scores after treatment.
Acupuncture, rather than sham or placebo acupuncture, may lead to long-term improvements on clinical outcomes and pain neuromediator values. Changes in serum serotonin and SP levels may be a valuable explanation for acupuncture mechanisms in FM treatment.
本研究旨在评估针刺治疗对纤维肌痛(FM)患者血清 5-羟色胺(5-HT)和 P 物质(SP)水平及临床参数的影响。
这是一项随机对照临床试验。75 例 FM 女性患者被随机分为真针刺组(AcG)、假针刺组(ShG)和模拟针刺组(SiG)。每周治疗 2 次,共治疗 4 周。在 8 次治疗前后评估血清 5-HT 和 SP 水平。患者在基线、末次治疗后及所有治疗结束后 1 和 3 个月采用视觉模拟评分(VAS)、压痛点数(NTP)、纤维肌痛影响问卷(FIQ)、贝克抑郁量表(BDI)和诺丁汉健康问卷(NHP)进行临床评估。
AcG 和 ShG 治疗后血清 5-HT 值显著升高(P<0.001 和 P<0.01),AcG 组的升高与其他两组也不同(P<0.01)。而 AcG 组 SP 水平降低,SiG 组升高(P=0.001)。在 AcG 组,治疗后几乎所有临床结局均显著改善,这些改善通常可持续 3 个月。在 ShG 组,治疗后 NTP、VAS、FIQ 和 BDI 评分也有显著变化,NTP 和 FIQ 评分的改善可持续 3 个月。在 SiG 组,治疗后仅 NTP、VAS 和 BDI 评分显著改善。
针刺治疗可能比假针刺或安慰剂针刺更能长期改善临床结局和疼痛神经递质水平。血清 5-HT 和 SP 水平的变化可能是针刺治疗 FM 的机制的一个有价值的解释。